C.M. Bidwell & Associates’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

C.M. Bidwell & Associates’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-270	Closed	-$2K	–	491
2018 Q2	$2K	Sell	270 -7,735	-97%	-$69.6K	﹤0.01%	388
2018 Q1	$81K	Buy	+8,005	New	+$67.2K	0.07%	210

C.M. Bidwell & Associates's JNP Position: Q3 2018 in Review

C.M. Bidwell & Associates sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 270 shares — an estimated $2K sold.

C.M. Bidwell & Associates first reported a position in JNP in Q1 2018 and held it in 2 quarters. The position peaked at $81K in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

C.M. Bidwell & Associates reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
C.M. Bidwell & Associates sold 270 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $2K.
C.M. Bidwell & Associates first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
C.M. Bidwell & Associates's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $81K in Q1 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.